Comparative effects of angiotensin converting enzyme inhibition (perindopril) or diuretic therapy on cardiac hypertrophy and sympathetic activity following myocardial infarction in rats
Tóm tắt
Từ khóa
Tài liệu tham khảo
Cleland JFG, Dargie HJ, Hodsman GP, et al. Captopril in heart failure: A double-blind controlled study.Br Heart J 1984;72:791–797.
Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: Beneficial effects of long-term therapy with captopril.Circulation 1985;72: 406–412.
Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: Results of the Consensus Study.N Engl J Med 1987;316:1429–1434.
Cody RJ, Franklin KW, Kluger J, Lavagh JH. Sympathetic responsiveness and plasma noradrenaline during therapy of chronic congestive heart failure with captopril.Am J Med 1982;72:791–797.
Cohn JN, Levine B, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.N Engl J Med 1984;311:819–823.
Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat.Circ Res 1985;57:84–95.
Michel J, Laftion A, Salzman J, et al. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction.Circ Res 1988;62:641–650.
Howes LG, Hodsman GP, Maccarrone C, et al. Cardiac 3,4-dihydroxyphenylethylene glycol (DHPG) and catecholamine levels in a rat model of left ventricular failure.J Cardiovasc Pharmacol 1989;13:348–352.
Tarlov SR, Langer SZ. The fate of3H norepinephrine released from isolated atria and vas deferens: Effect of field stimulation.J Pharmacol Exp Ther 1971;179:186–197.
Jackman G, Snell J, Skews H, Bobik A. Effects of noradrenergic neuronal activity on 3,4-dihydroxyphenylethylene glycol (DHPG) levels. Quantitation by high performance liquid chromatography.Life Sci 1982;31:923–929.
Howes LG, Summers RJ, Rowe PR, Louis WJ. The simultaneous determination of 3,4-dihydroxyphenylethylene glycol, 3,4-dihydroxyphenylacetic acid and catecholamines in brain tissue by high performance liquid chromatography with electrochemical detection.Neurosci Lett 1983;38:327–332.
Howes LG, Summers RJ, Rowe PR, Louis WJ. Measurement of central noradrenergic activity in spontaneously hypertensive rats: A comparison of free, 3,4-dihydroxyphenylethylene glycol levels with FLA-63 induced noradrenaline depletion.J Hypertens 1985;3:237–242.
Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarct size and left ventricular function in rats.Circ Res 1979;44:503–512.
Fletcher PJ, Pfeffer JM, Pfeffer MA, Braunwald E. Left ventricular diastolic pressure-volume relation in rats with healed myocardial infarction: Effects on systolic function.Circ Res 1981;49:618–626.
Tsunoda K, Hodsman GP, Sumithran E, Johnston CI. Atrial natriuretic peptide in chronic left heart failure in the rat: A correlation with ventricular dysfunction.Circ Res 1986; 59:256–261.
Antonaccio MJ, Kerwin L. Pre and postjunctional inhibition of vascular angiotensin II in hypertension and antihypertensive action of captopril.Hypertension 1981;3(Suppl 1): 154–162.
Rechtman MP, Eshac EJ, Boura AL, et al. Attenuation of pressor responses to sympathetic stimuli in the rat by enalapril.Clin Exp Pharmacol Physiol 1986;13:691–697.
Hirsch AT, Dzau VJ, Creager MA. Baroreceptor function in congestive heart failure: Effect on neurohumoral activation and regional vascular resistance.Circulation 1987; 75:IV36-IV48.
Bickerton RK, Buckley JP. Evidence for a central mechanism in angiotensin induced hypertension.Proc Soc Exp Biol Med 1961;106:834–836.
Malliani A, Pagani M. The role of the sympathetic nervous system in congestive heart failure.Eur Heart J 1983; 4(Suppl. A):49–54.
Lake CR, Ziegler MG, Coleman MD, Kopin IJ. Hydrochlorothiazide-induced sympathetic hyperactivity in hypertensive patients.Clin Pharmacol Ther 1979;26:428–432.